Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma

Clinical trial NCT06893887 · RECRUITING

Trial details

NCT number: NCT06893887
Sponsor: Nanjing Tianyinshan Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma(HCC)

Start date: 2025-05-22
Primary completion: 2027-03-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.